DNGFF

Fair Value

Price (monthly) Fair value line (dashed = analyst estimates) above fair value below fair value
Overvalued
+47%
vs fair value
Price
$2.8
Fair value
$1.91
Today's multiple
14.5x
Fair value multiple
10.6x
Typical multiple, 20y
9.7x
Adjusted EPS growth rate
1.0%
Trailing 12M adjusted EPS
$0.19

Results are highly cyclical for DNGFF, so multiple-based fair value is less reliable here.

FY20062007200820092010201120122013201420152016201720182019202020212022202320242025E2026E2027E2028E
High1.801.702.101.051.050.820.850.801.741.741.781.58
Low1.371.351.040.680.820.590.590.750.690.930.840.81
Adj EPS0.110.230.020.120.190.240.170.180.100.03-0.110.040.060.060.090.110.140.130.130.15E0.19E0.22E0.25E
Chg/Yr+101%-93%+620%+63%+25%-27%+2%-45%-69%-464%+55%+8%+46%+32%+20%-3%-2%+18%+24%+16%+12%
Div0.000.000.000.000.000.020.030.140.230.110.070.000.000.130.220.220.270.050.07
How these numbers are calculated

Fair value (10.6x) multiplies each year's earnings per share by a growth-based multiple: steady growers (5–15% a year) get 15x, faster growers get their growth rate as the multiple (capped at 30x), and slower growers step down below 15x. DNGFF has grown earnings about 1.0% a year, so the line uses 10.6x.

Typical multiple (9.7x) is what investors have actually paid for DNGFF: each of the last 20 fiscal years' average share price divided by that year's earnings per share, taking the median (loss years excluded). It shows how the market has historically priced this specific company, next to the general fair-value rule.

Today's multiple (14.5x) is what the market is paying right now: the current price divided by the last twelve months of earnings (the four most recent reported quarters). Compare it to the two reference multiples above to see whether today's pricing is rich or cheap.

Earnings are adjusted figures on the same basis analysts forecast, built from reported quarters; years beyond the last completed fiscal year use the analyst consensus (dashed). The verdict calls a stock over- or undervalued only when the price sits more than 10% from the fair value line. Analyst estimates for this listing are published in its home currency; they are converted to the reported basis using the historical relationship between the two.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.